Keywords: imclone, initiates, imc-3g3, ph, trial, new, york

ImClone initiates IMC-3G3 Ph I trial

Article | 08 January 2007

Print This

New York, USA-based ImClone Systems says it has commenced patient treatment in a Phase I clinical trial of its fully-human ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in